Multiplex Bead Array Assay Of A Panel Of Circulating Cytokines And Growth Factors In Patients With Albuminuric And Non-Albuminuric Diabetic Kidney Disease

A panel of cytokines and growth factors, mediating low-grade inflammation and fibrosis, was assessed in patients with type 2 diabetes (T2D) and different patterns of chronic kidney disease (CKD). Patients with long-term T2D (N = 130) were classified into four groups: no signs of CKD; estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m(2)without albuminuria; albuminuria and eGFR >= 60 mL/min/1.73 m(2); albuminuria and eGFR <60 mL/min/1.73 m(2). Thirty healthy subjects were acted as control. Twenty-seven cytokines and growth factors were assessed in serum by multiplex bead array assay. Serum hs-CRP, urinary nephrin, podocine, and WFDC2 were measured by ELISA. Patients with T2D showed elevated IL-1Ra, IL-6, IL-17A, G-CSF, IP-10, MIP-1 alpha, and bFGF levels; concentrations of IL-4, IL-12, IL-15, INF-gamma, and VEGF were decreased. IL-6, IL-17A, G-CSF, MIP-1 alpha, and bFGF correlated negatively with eGFR; IL-10 and VEGF demonstrated negative associations with WFDC2; no relationships with podocyte markers were found. Adjusted IL-17A and MIP-1 alpha were predictors of non-albuminuric CKD, IL-13 predicted albuminuria with preserved renal function, meanwhile, IL-6 and hsCRP were predictors of albuminuria with eGFR decline. Therefore, albuminuric and non-albuminuric CKD in T2D patients are associated with different pro-inflammatory shifts in the panel of circulating cytokines.